These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33579840)

  • 41. Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.
    Smith VD; Bachstetter AD; Ighodaro E; Roberts K; Abner EL; Fardo DW; Nelson PT
    Brain Pathol; 2018 Mar; 28(2):264-273. PubMed ID: 28281308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TDP-43 Pathology Exacerbates Cognitive Decline in Primary Age-Related Tauopathy.
    Smirnov DS; Salmon DP; Galasko D; Edland SD; Pizzo DP; Goodwill V; Hiniker A
    Ann Neurol; 2022 Sep; 92(3):425-438. PubMed ID: 35696592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns of amygdala region pathology in LATE-NC: subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies.
    Cykowski MD; Arumanayagam AS; Powell SZ; Rivera AL; Abner EL; Roman GC; Masdeu JC; Nelson PT
    Acta Neuropathol; 2022 May; 143(5):531-545. PubMed ID: 35366087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cognitive trajectories preluding the onset of different dementia entities: a descriptive longitudinal study using the NACC database.
    Liampas I; Dimitriou N; Siokas V; Messinis L; Nasios G; Dardiotis E
    Aging Clin Exp Res; 2024 May; 36(1):119. PubMed ID: 38780681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation of neuropathology with cognitive decline among older persons without dementia.
    Boyle PA; Yu L; Wilson RS; Schneider JA; Bennett DA
    Front Aging Neurosci; 2013; 5():50. PubMed ID: 24058343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants of confrontation naming deficits on the Boston Naming Test associated with transactive response DNA-binding protein 43 pathology.
    Robinson CG; Goodrich AW; Weigand SD; Pham NTT; Carlos AF; Buciuc M; Murray ME; Nguyen AT; Reichard RR; Knopman DS; Petersen RC; Dickson DW; Utianski RL; Whitwell JL; Josephs KA; Machulda MM
    J Int Neuropsychol Soc; 2024 Jul; 30(6):575-583. PubMed ID: 38525671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease.
    Tosun D; Yardibi O; Benzinger TLS; Kukull WA; Masters CL; Perrin RJ; Weiner MW; Simen A; Schwarz AJ;
    Alzheimers Dement; 2024 Jan; 20(1):421-436. PubMed ID: 37667412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting functional decline in aging and Alzheimer's disease with PET-based Braak staging.
    Macedo AC; Therriault J; Tissot C; Fernandez-Arias J; Ferreira PCL; Vitali P; Servaes S; Rahmouni N; Vermeiren M; Bezgin G; Lussier FZ; Stevenson J; Wang YT; Socualaya KQ; Kunach P; Nazneen T; Hosseini SA; Pallen V; Stevenson A; Ferrari-Souza JP; Bellaver B; Leffa DT; Ng KP; Zimmer ER; Pascoal TA; Gauthier S; Rosa-Neto P
    Brain Commun; 2024; 6(2):fcae043. PubMed ID: 38482373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
    Hohman TJ; Bell SP; Jefferson AL;
    JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Symptomatic Profile and Cognitive Performance in Autopsy-Confirmed Limbic-Predominant Age-Related TDP-43 Encephalopathy With Comorbid Alzheimer Disease.
    Gauthreaux K; Mock C; Teylan MA; Culhane JE; Chen YC; Chan KCG; Katsumata Y; Nelson PT; Kukull WA
    J Neuropathol Exp Neurol; 2022 Nov; 81(12):975-987. PubMed ID: 36264254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mixed neuropathologies and associations with domain-specific cognitive decline.
    Brenowitz WD; Hubbard RA; Keene CD; Hawes SE; Longstreth WT; Woltjer RL; Kukull WA
    Neurology; 2017 Oct; 89(17):1773-1781. PubMed ID: 28939667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frontotemporal lobar degeneration-related proteins induce only subtle memory-related deficits when bilaterally overexpressed in the dorsal hippocampus.
    Dayton RD; Wang DB; Cain CD; Schrott LM; Ramirez JJ; King MA; Klein RL
    Exp Neurol; 2012 Feb; 233(2):807-14. PubMed ID: 22177996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurodegenerative pathologies associated with behavioral and psychological symptoms of dementia in a community-based autopsy cohort.
    Nelson RS; Abner EL; Jicha GA; Schmitt FA; Di J; Wilcock DM; Barber JM; Van Eldik LJ; Katsumata Y; Fardo DW; Nelson PT
    Acta Neuropathol Commun; 2023 Jun; 11(1):89. PubMed ID: 37269007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The time course of motor and cognitive decline in older adults and their associations with brain pathologies: a multicohort study.
    Oveisgharan S; Wang T; Barnes LL; Schneider JA; Bennett DA; Buchman AS
    Lancet Healthy Longev; 2024 May; 5(5):e336-e345. PubMed ID: 38582095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropathology and cognitive performance in self-reported cognitively healthy centenarians.
    Ganz AB; Beker N; Hulsman M; Sikkes S; Netherlands Brain Bank ; Scheltens P; Smit AB; Rozemuller AJM; Hoozemans JJM; Holstege H
    Acta Neuropathol Commun; 2018 Jul; 6(1):64. PubMed ID: 30037350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.
    Abdelnour C; van Steenoven I; Londos E; Blanc F; Auestad B; Kramberger MG; Zetterberg H; Mollenhauer B; Boada M; Aarsland D;
    Mov Disord; 2016 Aug; 31(8):1203-8. PubMed ID: 27296778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A.
    Aoki N; Murray ME; Ogaki K; Fujioka S; Rutherford NJ; Rademakers R; Ross OA; Dickson DW
    Acta Neuropathol; 2015 Jan; 129(1):53-64. PubMed ID: 25367383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Relationship Between First Presenting Neuropsychiatric Symptoms in Older Adults and Autopsy-Confirmed Memory Disorders.
    Shaw JS; Leoutsakos JM; Rosenberg PB
    Am J Geriatr Psychiatry; 2024 Jun; 32(6):754-764. PubMed ID: 38296755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
    Gao J; Wang L; Gao C; Arakawa H; Perry G; Wang X
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165580. PubMed ID: 31678156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
    Bransby L; Lim YY; Ames D; Fowler C; Roberston J; Harrington K; Snyder PJ; Villemagne VL; Salvado O; Masters CL; Maruff P
    J Clin Exp Neuropsychol; 2019 Aug; 41(6):591-600. PubMed ID: 30924399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.